KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 122 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 4.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $442,386 | +27.7% | 113,724 | +11.6% | 0.00% | 0.0% |
| Q4 2022 | $346,518 | -19.2% | 101,917 | +29.6% | 0.00% | 0.0% |
| Q3 2022 | $429,000 | +410.7% | 78,657 | +321.1% | 0.00% | – |
| Q2 2022 | $84,000 | -39.1% | 18,680 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $138,000 | -50.9% | 18,680 | +27.9% | 0.00% | -50.0% |
| Q1 2020 | $281,000 | +20.6% | 14,610 | +20.4% | 0.00% | +100.0% |
| Q4 2019 | $233,000 | -63.9% | 12,130 | -82.4% | 0.00% | -75.0% |
| Q4 2018 | $645,000 | -5.6% | 68,835 | +71.7% | 0.00% | 0.0% |
| Q3 2018 | $683,000 | +21.1% | 40,090 | +20.9% | 0.00% | +33.3% |
| Q2 2018 | $564,000 | – | 33,170 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,200,396 | $30,084,000 | 1.72% |
| TFS CAPITAL LLC | 105,040 | $987,000 | 0.26% |
| Tekla Capital Management LLC | 500,324 | $4,703,000 | 0.20% |
| Piermont Capital Management Inc. | 51,080 | $480,000 | 0.11% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 55,793 | $524,000 | 0.09% |
| Candriam S.C.A. | 390,000 | $3,666,000 | 0.08% |
| Virtus ETF Advisers LLC | 27,446 | $258,000 | 0.08% |
| SECOR Capital Advisors, LP | 66,484 | $625,000 | 0.08% |
| Trexquant Investment LP | 29,007 | $273,000 | 0.04% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 32,196 | $303,000 | 0.04% |